Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,528,823 papers from all fields of science
Search
Sign In
Create Free Account
Neostigmine:MCnc:Pt:Ser/Plas:Qn
Known as:
Neostigmine:Massa concentratie:Moment:Serum of plasma:Kwantitatief
, ??????:????:????:??/??:??
, Neostigmin:KütlKons:Zml?:Ser/Plaz:Kant
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Neostigmine
Plas
Serum
Unit of Mass Concentration
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Comparison of Neostigmin Versus Sugammadex in Reversal of Neuromuscular Blockade after Abdominal Surgery of Obese Patients Whose Bmi ≥30
Osmangazi Tıp Dergisi
,
Osmangazi
,
Meryem Onay
2018
Corpus ID: 167212567
: Our aim is to compare neostigmin versus sugammadex in reversal of neuromuscular blockade of vecu-ronium after abdominal surgery…
Expand
2017
2017
[Functional respiratory imaging after neostigmine- or sugammadex-enhanced recovery from neuromuscular blockade in the anesthetised rat: a randomised controlled pilot study].
T. Schepens
,
G. Cammu
,
S. Maes
,
Benny Desmedt
,
W. Vos
,
K. Deseure
Revista Brasileira de Anestesiologia
2017
Corpus ID: 2905369
2017
2017
Perbandingan Efek Penambahan Neostigmin 50 µg dan 75 µg Pada Bupivakain Hiperbarik 0,5% 15 mg Terhadap Lama Kerja Blokade Sensorik dan Efek Samping Mual Muntah Pasca Operasi Anesti Spinal
Totok Kristiyono
,
D. Tamtomo
,
Marthunus Judin
2017
Corpus ID: 80461544
Latar Belakang: anestesi spinal menggunakan bupivakain hiperbarik banyak dipakai pada operasi untuk pasien dengan berbagai…
Expand
2015
2015
Bloqueo subaracnoideo: comparación bupivacaína hiperbárica más neostigmina vs bupivacaína hiperbárica en pacientes sometidos a resección trans uretral de próstata
Zárate Ahuatzin
,
José Alberto
2015
Corpus ID: 75355752
2013
2013
Perbandingan Penambahan Neostigmin 2 mg/kgBB dengan Fentanil 1 µg/kgBB dalam Bupivakain 0,125% sebagai Anestesi Kaudal terhadap Lama Analgesia
J. Alam
,
Ezra Oktaliansah
,
C. E. Boom
2013
Corpus ID: 71988053
Blokade kaudal dengan injeksi tunggal sering digunakan untuk penatalaksanaan nyeri intra dan pascabedah pada pasien pediatrik…
Expand
2011
2011
PERBANDINGAN ONSET DAN DURASI BLOK SYARAF SPINALANTARA PENAMBAHAN FENTANYL 12,5g DENGAN NEOSTIGMIN 50gPADA SUBARACHNOID BLOK DENGAN BUPIVAKAIN 0,5% 12,5mg HIPERBARIKUNTUK OPERASI DAERAH PANGGUL DAN…
Alfred Yos Wirawan
,
Sp.An-KAKV Kar I.G. Ngurah Rai Artika
2011
Corpus ID: 68956237
S Introduction : pinal anesthesia is increasingly popular in use, however, there are any problems include onset and duration that…
Expand
2008
2008
Impacto de la ropivacaína vía caudal sobre la relajación neuromuscular no despolarizante
J. A. C. Vela
,
J. Rodríguez
,
+4 authors
Elisa Rionda Díaz
2008
Corpus ID: 74310084
Objetivo: Determinar si la ropivacaína administrada mediante bloqueo caudal, prolonga el tiempo de acción del atracurio…
Expand
1974
1974
Atropine, Neostigmine and Airway Resistance
M. Kjellberg
,
J. Heinonen
Acta Anaesthesiologica Scandinavica
1974
Corpus ID: 2610235
This study was performed to find out whether the two common modes of administration of atropine and neostigmine used for reversal…
Expand
1964
1964
Zur Behandlung der Atropinvergiftung mit Parasympathicomimetica
L. Lendle
,
H. Paul
,
H. Ri
Naunyn-Schmiedebergs Archiv für Experimentelle…
1964
Corpus ID: 37484299
ZusammenfassungDie gute Verträglichkeit von sehr hohen Atropindosen bei Vergiftungen mit Alkylphosphaten und die Beobachtung über…
Expand
1962
1962
Gleichzeitiges Auftreten zweier zentraler Atmungsrhythmen und ihre Koordination
K. Hansen
Naunyn-Schmiedebergs Archiv für Experimentelle…
1962
Corpus ID: 11592287
DFP 1,0--2,0 mg/kg intravenSs) zu einer Versthrkung der exspiratorischcn Reflexe fiihrten. Das Reaktionsmaximum wird durch…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE